King, Martin https://orcid.org/0000-0002-4097-5107
Mirić, Grgur
Galbreath, Robert
Fiano, Ryan
Moningi, Shalini
Wallner, Kent
Orio, Peter
Article History
Received: 26 February 2025
Revised: 13 August 2025
Accepted: 2 September 2025
First Online: 11 September 2025
Competing interests
: Martin King has received research funding from Palette Life Sciences, Bayer Healthcare, and AstraZeneca, outside of the submitted work. Grgur Mirić has served as a consultant for Theragenics, outside of the submitted work. Robert Galbreath has received a grant from Theragenics for statistical analysis of the submitted work. Peter Orio has received research funding, consulting fees, and stock for Palette Life Sciences, outside of the submitted work.
: All methods were performed in accordance with the relevant guidelines and regulations. Institutional-board approval has been obtained from the Bethany Ethical Research and Animal Care Committee (reference number S24-16). In addition, all patients signed an IRB-approved informed consent form at the time of treatment, which included consent for their clinical data to be used in future research.